COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 2641: Articles 26401-26410  | Next

COVID-19 projections for reopening Connecticut
Crawford, F. W., Li, Z. R., Morozova, O.
10.1101/2020.06.16.20126425 — Posted: 2020-06-19
Syndromic surveillance insights from a symptom assessment app before and during COVID-19 measures in Germany and the United Kingdom: results from repeated cross-sectional analyses
Mehl, A., Bergey, F., Cawley, C., Gilsdorf, A.
10.1101/2020.06.16.20126466 — Posted: 2020-06-19
A high-throughput strategy for COVID-19 testing based on next-generation sequencing
Huang, J., Zhao, L.
10.1101/2020.06.12.20129718 — Posted: 2020-06-19
PERSONAL PROTECTIVE EQUIPMENT (PPE) USING IN ANTALYA 112 EMERGENCY AMBULANCE SERVICES DURING OUTBREAK
GULSEN, M. F., KURT, M., KALELI, I., ULASTI, A.
10.1101/2020.06.16.20129171 — Posted: 2020-06-19
On Identifying and Mitigating Bias in the Estimation of the COVID-19 Case Fatality Rate
Angelopoulos, A. N., Pathak, R., Varma, R., Jordan, M. I.
10.1101/2020.06.15.20038489 — Posted: 2020-06-19 Discussion: Onsite
A longitudinal study of immune cells in severe COVID-19 patients.
Payen, D., Cravat, M., Maadadi, H., Didelot, C., Prosic, L., Dupuis, C., Losser, M.-R., De Carvalho Bittencourt, M.
10.1101/2020.06.16.20130914 — Posted: 2020-06-19 Discussion: Onsite
Potential involvement of monoamine oxidase activity in SARS-COV2 infection and delirium onset
Cuperlovic-Culf, M., Cunningham, E. L., Surendra, A., Pan, X., Bennett, S. A. L., Jung, M., McGuiness, B., Passmore, A. P., McAuley, D., Beverland, D., Green, B. D.
10.1101/2020.06.16.20128660 — Posted: 2020-06-19
Does Gender or Religion Contribute to the Risk of COVID-19 in Hospital Doctors?
Daga, S., Jafferbhoy, S., Menon, G., Ali, M., Chakravorty, S., Ghani, S., Burney, A., Bamrah, J., Mehta, R., Chakravorty, I.
10.1101/2020.06.15.20125450 — Posted: 2020-06-19
Variant analysis of SARS-CoV-2 strains in Middle Eastern countries
Bindayna, K. M., Crinion, S.
10.1101/2020.06.18.156810 — Posted: 2020-06-18
Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19
Mulgaonkar, N. S., Wang, H., Mallawarachchi, S., Ruzek, D., Martina, B., Fernando, S.
10.1101/2020.06.18.158196 — Posted: 2020-06-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).